Methygene initiate second Phase I trial of c-Met inhibitor MGCD265 in Cancer

Posted on June 12, 2008 by crimsoncanary

MethylGene have initiated a second phase I trial of its c-Met inhibitor MGCD-265 in patients with solid tumours

Filed under: kinase | Tagged: , , , , , | Comments Off

Tykerb receives conditional EU marketing approval for HER2 breast cancer

Posted on June 12, 2008 by crimsoncanary

GlaxoSmithKline have received a conditional marketing authorisation from the european autorities for lapatinib (Tyverb, Tykerb). The approval is for the use of lapatinib in advanced or metastatic HER2 positive breast cancer in combination with capecitabine.

Filed under: kinase | Tagged: , , , , , , , , , , , , , | Comments Off

Rigels Syk inhibitor R788 enters Phase 2b trials in RA

Posted on June 12, 2008 by crimsoncanary

Rigel have announced that its Syk inhibitor R788 has entered phase IIb clinical trials in Rheumatoid Arthritis (RA)

Filed under: kinase | Tagged: , , , , , | Comments Off